SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-080035
Filing Date
2022-07-15
Accepted
2022-07-15 08:20:24
Documents
2
Period of Report
2022-07-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2220857-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2220857-1_3seq1.xml 3 1661
2 EXHIBIT 24.1 tm2220857d1_ex24-1.htm EX-24.1 8528
  Complete submission text file 0001104659-22-080035.txt   11699
Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
Astria Therapeutics, Inc. (Issuer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Morabito Christopher (Reporting) CIK: 0001859284 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37467 | Film No.: 221084311